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INTRODUCTION
Nocturia is one of the most prevalent and bothersome lower 
urinary tract symptoms (LUTS) [1]. According to several previ-
ous studies, nocturia has detrimental effects on quality of life 
(QoL) and overall health, mainly due to sleep disturbances [2-
4]. According to the 2002 International Continence Society 
(ICS) definition, nocturia is defined as waking at night to void, 
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Purpose: The aims of this study were to assess the prevalence of nocturia and nocturnal polyuria (NP) and to define new cut-
off values according to age and sex for both conditions.
Methods: Data from a population-based prevalence survey conducted among a random sample of 2,128 adults were analyzed 
in this study. Participants were requested to fill out a questionnaire including the International Continence Society (ICS) defi-
nitions of lower urinary tract symptoms and the International Consultation on Incontinence Questionnaire - Short Form. Ad-
ditionally, a 1-day bladder diary was given to each individual. The participants were divided into 5 age groups. The prevalence 
of nocturia was calculated based on definitions of nocturia as ≥1 voiding episodes, ≥2 episodes, and ≥3 episodes. NP was 
evaluated according to the ICS definition. The mean±standard errors and 95th percentile values were calculated in each 
group as new cutoff values for NP.
Results: The prevalence of nocturia was estimated as 28.4%, 17.6%, and 8.9% for ≥1, ≥2, and ≥3 voiding episodes each 
night, respectively. When nocturia was defined as 2 or more voiding episodes at night, the prevalence decreased significantly. 
The mean NP index was 29.4%±15.0% in men and 23.1%±11.8% in women. For the age groups of <50 years, 50–59 years, 
and ≥60 years, the new cutoff values for the diagnosis of NP were calculated as 48%, 69%, and 59% for men and 41%, 50%, 
and 42% for women, respectively.
Conclusions: We found that the definition of nocturia was still controversial and that waking up once for voiding might be 
within the normal spectrum of behavior. The definition of NP should be modified, and new cutoff values should be defined 
using the data presented in our study and in other forthcoming studies.
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which applies to any number of voiding episodes at any time 
during the night [5]. This definition, however, lacks sensitivity 
regarding how bothersome the symptom is. Some authors have 
suggested that getting up to void once a night may be normal, 
that most people who void less than 2 times per night generally 
do not suffer from their condition, and that nocturia has been 
shown to be associated with more serious consequences when 
nocturnal voiding occurs ≥2 times on a regular basis [4,6].
 Nocturnal polyuria (NP) is defined as the production of an 
abnormally large volume of urine during sleep. According to 
the most recent ICS definition, NP is present when an increased 
proportion of the 24-hour output occurs at night [5]. Frequency 
volume charts are used to determine the presence of NP. The 
most widely used index is the NP index (NPI), which is the ra-
tio of nocturnal urine production (NUP) to 24-hour urine pro-
duction expressed as a percentage [7]. Rembratt et al. [8] classi-
fied the definitions of NP as absolute, relative, and functional. 
Asplund et al. [9] proposed an absolute definition (NUP≥0.9 
mL/min), which they later proposed modifying to 1.3 mL/min. 
Other definitions also have been presented by different authors 
[10-12].
 It has been pointed out that the suggested definitions of NP, 
which refer to the day-to-night ratio in urine production, are 
not based on normal distributions and have not been properly 
validated [13]. Similarly, the panelists at the 2012 New England 
Research Institute (NERI) Nocturia Advisory Conference 
agreed that more research is required to determine appropriate 
population-based norms for NP, as well as to set a more reliable 
threshold for nocturia [4]. Additional concerns have been re-
ported at the Nocturia Think Tank (NTT) panel in 2014 [14]. 
Therefore, the definitions of both nocturia and NP are contro-
versial, as is the cutoff point for NP. In this study, we aimed to 
assess the prevalence of both conditions and to define new cut-
off values for nocturia and NP in the population.
MATERIALS AND METHODS
The data analyzed in this study were drawn from a population-
based survey of the prevalence of LUTS, overactive bladder, 
and urinary incontinence that was conducted among a random 
sample of 2,128 women and men aged ≥18 years. The selection 
of the participants was described in detail in our recently pub-
lished study [15]. The local ethics committee and the review 
board of Pamukkale University School of Medicine (approval 
number: 1208) approved the study. Participants were requested 
to fill out a questionnaire including the ICS definitions of 
LUTS, including increased daytime frequency, nocturia, urgen-
cy, slow stream, splitting or spraying, intermittent stream, hesi-
tancy, straining, terminal dribble, feeling of incomplete empty-
ing, and postmicturition dribble, as well as the International 
Consultation on Incontinence Questionnaire - Short Form 
(ICIQ-SF). Additionally, a bladder diary was given to each indi-
vidual to fill out for a 24-hour period.
 The study was mainly conducted at family health centers, 
and the primary care physicians and their assistant nurses had 
previously been trained in obtaining data for the study. The as-
sessment of height, weight, body mass index, vital signs, and 
urinalysis with a dip-stick test was also performed by these staff 
members. Participants with a positive dip-stick test for nitrites 
were excluded from the study. The individuals who agreed to 
participate in the study were instructed by the staff about the 
study questionnaires and how to complete the bladder diaries 
accurately.
 The participants were suggested to empty their bladder on 
the first morning, and after emptying their bladder, to record all 
data about fluid intake and voiding with the event time in hours 
and minutes. They were requested to write down the volume of 
intake, voiding time and volume, and times of sleeping and 
waking up. Special duck-shaped scaled urine containers were 
provided for this study and given to each participant to mea-
sure and record voiding volumes accurately. The recording of 
micturition ended with the first voiding after waking up the 
next morning. The volume of this voiding was recorded as the 
last voiding.
 In the participants who did not report any nocturia or record 
any voiding during the night, the voided volume the next 
morning was recorded as the nocturnal urine volume (NUV). 
A 24-hour urine output of more than 40 mL/kg was considered 
polyuria. The prevalence of NP was also calculated according to 
previous definitions, which were presented above.
 The participants were divided into 5 age groups (18–29 years, 
30–39 years, 40–49 years, 50–59 years, and ≥60 years). The 
prevalence of nocturia was calculated using the ICS definition 
of ≥1 voiding episode per night. We also classified the respon-
dents with ≥2 and ≥3 nocturnal voiding episodes per night 
into separate groups for comparison and further analysis.
 To determine a previously undefined reference range or val-
ue, it is common to establish the reference range as including all 
available data within the 95th percentile as a way of distinguish-
ing normal from high or abnormal values. This is a prediction 
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rather than a strict definition of a constant, and in a normally 
distributed sample this corresponds to the mean plus 1.645 
times the standard deviation (SD). The upper limit of this refer-
ence range is usually used as the cutoff point [7]. In our study, 
the mean ±standard error (SE) and 95th percentiles (mean+ 
[1.645×SD]) were calculated in each group to define the NP 
cutoff. Statistical analysis was performed using SPSS ver. 17.0 
(SPSS Inc., Chicago, IL, USA). 
RESULTS
Of the 2,128 people surveyed, 1,555 (74%) agreed to participate 
in the study, and of those, 856 (55%) filled in the bladder diaries 
accurately and returned them. Of the missing diaries, 570 
(81.5%) were not filled in or returned. We could not read the 
handwriting in 26 diaries (3.7%), 42 (6%) had missing sleeping 
or waking times, and 61 (8.7%) had missing intake or voided 
volumes. We did not find a significant difference in subscale 
scores regarding ICS definitions, symptom severity, and ICIQ-
SF parameters between responders and others (P>0.05).
 The characteristics of the study population, comorbidities, 
and medications are given in Table 1, and selected bladder diary 
data are presented in Table 2. The prevalence of nocturia in each 
group is given in Table 3. The prevalence of nocturia significant-
ly increased with age. When nocturia was defined as 2 or more 
voiding episodes at night, its prevalence decreased significantly 
(Fig. 1).
 In men, the mean±SD NPI values for the age groups <50 
years, 50–59 years, and ≥60 years were 23.3% ±13.4%, 
29.3%±17.1%, and 33.2%±13.3%, respectively. The mean±SD 
NPI values for the same age groups were 22.2% ±11.5%, 
25.5% ±13.0%, and 22.7% ±10.9% in women. NP increased 
with age in men, but no linear correlation with age was ob-
served in women (Fig. 2). When the 95th percentile was used 
to distinguish normal from abnormal values, the cutoff values 
for the diagnosis of NP in the age groups of <50 years, 50–59 
years and ≥60 years were 48%, 69%, and 59% for men and 41%, 
50%, and 42% for women, respectively.
 In order to compare our findings with those of previous 
studies, a similar calculation was performed regarding the older 
definitions of NP, and the cutoff value (95th percentile) for the 
nocturia index (NI) was 2.6 for men and 2.5 for women. The 
same cutoff for NUP (mL/hr) was 159 for men and 137 for 
Table 1. Characteristics and comorbidities of the study population
Variable Men (n=636)
Women 
(n=919)
Total 
(n=1,555)
Sex 40.9 59.1 100
Age group (yr)
   18–29 
   30–39 
   40–49 
   50–59 
   ≥60 
  
18.3
23.8
22.9
18.6
16.4
  
22.3
28.6
20.8
15.2
13.1
  
20.7
26.6
21.6
16.6
14.5
Comorbidities
   Hypertension
   Diabetes mellitus
   Hyperlipidemia
   COPD or asthma
   Cerebrovascular accident
   Thyroid diseases
   Coronary artery disease
   Psychiatric diseases
  
15.3
12.4
6.5
2.9
1.6
0.7
5.9
1.0
  
15.7
10.2
4.9
3.6
0.2
7.5
2.6
2.0
  
15.5
11.0
5.5
3.4
0.7
5
3.7
1.6
Medications
   Diuretics
   Antihyperlipidemics
   Antihypertensivesa)
   Antidiabetics/insulin   
   Antidepressants
   Asthma or COPD medications
   Thyroid replacement
38.0
6.5
4.2
6.8
6.8/0.0
0.3
1.6
0.3
43.2
6.6
3.1
6.2
5.6/0.5
3.1
0.5
4.6
41.4
6.5
3.5
6.6
6.1/0.4
2.1
0.9
3.0
Values are presented as percentage.    
COPD, chronic obstructive pulmonary disease.   
a)Antihypertensives other than antidiuretics.  
Table 2. Bladder diary data of the study group      
Bladder diary data Men (n=307) Women (n=549) Total (n=856)
Fluid intake (mL) 2,358±938 (400–6,100) 2,248±988 (350–6,600) 2,287 ±971 (350–6,600)
24-Hour urine output (mL) 1,568±863 (400–6,840) 1,747±1,132 (290–8,900) 1,682±1,046 (290–8,900)
24-Hour voiding frequency 6.6±2.5 (2–15) 7.8±3.0 (2–31) 7.4±2.9 (2–31)
Nighttime urine output 492±326 (100–1,400) 446±307 (60–1,500) 460±312 (60–1,500)
Maximum voided volume 382±167 (100–850) 404±185 (100–1,200) 396±179 (100–1,200)
Nocturia index 1.37±0.71 (0.22–3.00) 1.25±0.70 (0.20–4.00) 1.29 ±0.71 (0.20–4.00)
Values are presented as mean±standard deviation (range).      
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women. When NUV was adjusted for body weight, the 95th 
percentile values were 16.4 mL/kg and 14.8 mL/kg for men and 
women, respectively. 
 The prevalence of NP according to the current ICS definition 
was 44% in participants under 65 years of age and 31.3% in 
participants aged 65 years or older. The prevalence of NP ac-
cording to the older definitions was also calculated and found 
to be between 14.6% and 42.4% (Table 4).
DISCUSSION
Although the consensus ICS definition employs a nocturia cut-
off of 1 voiding episode per night, some authors have suggested 
that a cutoff of 2 voiding episodes per night might be more clini-
cally relevant and better correlated to QoL impairment [16]. 
Our results showing a significant decrease in the prevalence of 
nocturia according to the latter definition support this sugges-
tion. Studies of the effects of nocturia on QoL have shown that 
most people with less than 2 voiding episodes per night general-
ly have only minimal bother from the condition, and that noc-
turia is more likely to have more serious consequences only 
when ≥2 voiding episodes per night occur on a regular basis [6]. 
Although nocturia literally refers to waking up to void, as de-
fined by the ICS, a certain cutoff point is needed when it is used 
to describe a symptom or a clinical disease that has known con-
sequences for health and health-related QoL. The current defi-
nition may include individuals who do not consider their noc-
turia bothersome [14]. Alternatively, new terms such as “bother-
some nocturia” may be used to distinguish nocturia as a disease 
from the term used for waking up to void. 
Table 3. Prevalence of nocturia in each age group according to the International Continence Society definition and alternative definitions
Definition
Age group (yr)
18–29 30–39 40–49 50–59 ≥60 Total
Men
   Nocturia as ≥1 voiding episodea)
   Nocturia as ≥2 voiding episodes
   Nocturia as ≥3 voiding episodes
  
5.2
0
0
  
10.6
3.3
1.3
  
23.4
13.8
6.9
  
34.7
22.9
9.3
  
57.7
48.1
27.9
  
24.8
16.1
8.2
Women
   Nocturia as ≥1 voiding episodea)
   Nocturia as ≥2 voiding episodes
   Nocturia as ≥3 voiding episodes
  
19.1
11.8
5.4
  
21.5
11.1
5.4
  
35.3
22.1
11.6
  
43.9
28.1
15.8
  
50.0
30.0
14.2
  
31.0
18.6
9.4
All
   Nocturia as ≥1 voiding episodea)
   Nocturia as ≥2 voiding episodes
   Nocturia as ≥3 voiding episodes
  
14.1
7.5
3.4
  
17.5
8.3
3.9
  
30.1
18.5
9.6
  
39.7
25.7
12.8
  
53.6
38.4
20.5
  
28.4
17.6
8.9
Values are presented as percentage.      
a)International Continence Society definition.      
18–29 30–39 40–49 50–59 Total
Men
Age group (yr) 
≥60
70
60
50
40
30
20
10
0
Nocturia ≥3
Nocturia ≥2
Nocturia ≥1*
Nocturia ≥3
Nocturia ≥2
Nocturia ≥1*
18–29 30–39 40–49 50–59 Total
Women
Age group (yr) 
≥60
60
50
40
30
20
10
0
Nocturia ≥3
Nocturia ≥2
Nocturia ≥1*
18–29 30–39 40–49 50–59 Total
All
Age group (yr) 
≥60
60
50
40
30
20
10
0
Fig. 1. The prevalence (%) of nocturia in age groups defined according to various cutoffs for nocturia (in terms of number of voiding 
episodes per night). *International Continence Society definition.
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 Population-based studies have shown age to be the most im-
portant risk factor for nocturia [17]. In our study, the prevalence 
of nocturia increased with age in both sexes. Our results also 
confirmed those of previous studies that showed sex to have a 
significant impact, with the prevalence of nocturia was generally 
greater in women among young adults, but greater in men 
among the elderly [17].
 The ICS standardization report on terminology states that 
the normal range of NUP differs with age and that normal 
ranges remain to be defined [13]. A gap exists between the age 
groups that have been defined (young adults and adults >65 
years) and there is a large range between the defined cutoff val-
ues. For example, what should the NP cutoff be for a man aged 
63 years? Should the answer be 20%, 33%, or somewhere be-
tween these 2 cutoff values?
 In a normally distributed dataset, if the normal and abnor-
mal values are not known and need to be calculated, the 95th 
percentile is a common reference point to distinguish abnormal 
values from normal. In a recent study, this method was used to 
determine the cutoff in a normally distributed sample of 894 
volunteers without urological complaints, and a NPI of more 
than 53% was advocated as the NP cutoff [7]. The utility of this 
18–29 30–39 40–49 50–59 Total
Mean NP Index
Age group (yr) 
%
≥60
36
32
28
24
20
16
All
Men
Women
Upper bound
Lower bound
95th percentile
Mean±SE
18–29 30–39 40–49 50–59 Total
Mean NP Index (All)
Age group (yr) 
%
≥60
70
60
50
40
30
20
10
0
Upper bound
Lower bound
95th percentile
Mean±SE
<50 50–59
48
69
59 56
41
50
42 44
>60 Total
Mean NP Index (Men)
Age group (yr) 
%
80
70
60
50
40
30
20
10
0
Upper bound
Lower bound
95th percentile
Mean±SE
<50 50–59 >60 Total
Mean NP Index (Women)
Age group (yr) 
%
80
70
60
50
40
30
20
10
0
Fig. 2. Mean±standard error (SE) NPI values with 95% confidence intervals and 95th percentiles for all age groups. NP, nocturnal 
polyuria; NPI, nocturnal polyuria index.
Table 4. Prevalence of nocturnal polyuria in our population according to the definitions in the previous literature   
Study Definition Study group Men (%) Women (%) Overall (%)
Asplund et al. [9] NUP ≥54 mL/hr Men (50–78 yr) 42.2 42.4 42.3
Asplund et al. [9]a) NUP ≥78 mL/hr Men (50–78 yr) 26.6 22.9 24.0
Homma et al. [10] NUP ≥10 mL/kg All (20–89 yr) 17.7 16.7 17.0
Blanker et al. [11] NUP ≥90 mL/hr All (60–74 yr) 18.8 14.6 15.9
Weiss et al. [12] NI >1.5 Men (65–68 yr) 35.3 28.0 30.2
NUP, nocturnal urine production; NI, nocturia index (the ratio of NUP to functional bladder capacity).   
a)Alternative definition by Asplund et al. [9] (NUP ≥1.3 mL/min).      
42
49
43
54 56
49
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method, however, was criticized in an editorial comment on 
the same article. 
 In our study, which was conducted on a population-based 
sample of 856 people, we found a mean NPI of 29.4% in men 
and 23.1% in women. We suggest that the NP cutoffs corre-
sponding to the 95th percentile for the age groups of <50 years, 
50–59 years and ≥60 years should be 48%, 69%, and 59% for 
men and 41%, 50%, and 42% for women, respectively. We in-
cluded all participants and did not repeat the analysis for those 
without nocturia or polyuria. In a recent study, further analysis 
of the subgroup without nocturia and polyuria did not reveal 
any significant differences [7]. Our study is the first to use the 
95th percentile to define a cutoff for NP in a population-based 
study. Our results confirm the findings of van Haarst and Bosch 
[7] who used the same method in asymptomatic volunteers 
who were recruited from hospital staff, their families, and pa-
tient families. However, our suggestions should not be per-
ceived as strict definitions. Further studies validating or modi-
fying our cutoff values would clarify this issue. 
 The 2012 NERI Nocturia Advisory Conference report pre-
sented a PubMed search that yielded 58 studies containing 16 
definitions of NP. This report concluded that even the most 
widely accepted definition of NP, from the 2002 ICS report, was 
lacking in scientific rigor [4]. Our study is the first to show high 
prevalence rates in the population using the current definition 
of NP. According to the latest and the most widely accepted 
definition of NP, the prevalence of NP in our population was 
44% in adults <65 years and 31.3% in adults ≥65 years of age. 
Since 90% of our adult population was younger than 65 years, 
more than 40% of our adult population would be diagnosed 
with NP if the current terminology is used. This observation 
was the main incentive for us to conduct this study. The esti-
mates used in the ICS terminology report for NP were based on 
very small sample sizes: 18 subjects in the study used to develop 
the young adult cutoff and 45 subjects in the study used to de-
velop the cutoff for the elderly [4,18,19]. We suggest that a cut-
off should neither deprive certain patients of effective treatment 
that they actually need nor cause overtreatment for healthy 
people, exposing them to the side effects of certain medications. 
The criterion of the 95th percentile, which was used for these 
calculations, can be modified according to further studies cal-
culating the sensitivity and specificity of the defined cutoffs. In 
the latest NTT report, it was stated that the NPI (33%) should 
not be used without correcting for age and excluding 24-hour 
polyuria.  
 The alternative definitions of NP suggested in the past also 
resulted in high prevalence rates of NP. According to the defini-
tion of Blanker et al. (NUP≥90 mL/hr), 15.9% of our popula-
tion had NP [11]. The Krimpen study evaluated this definition 
and estimated that 28% of men with nocturia had NP, com-
pared with 8% of those without nocturia [20]. Asplund et al. [9] 
defined NP as the rate of NUP≥0.9 mL/min at night. However, 
the authors suggested that a lower limit of NUP≥1.3 mL/min 
might be more appropriate for selection purposes in future tri-
als [8,9]. When we applied the suggested threshold to our study 
population, the prevalence of NP was 26.6% in men and 22.9% 
in women. Another definition of NP, NUP adjusted for body 
weight (>10 mL/kg), was suggested by Homma et al. [10]. This 
threshold was chosen based on the upper quartile from a sam-
ple of 67 adults without any LUTS. In our study population, 
when we calculated the cutoff for the 95th percentile, it was 
16.4 mL/kg for men and 14.8 mL/kg for women.
 Another way of defining NP is NI, which was defined by 
Weiss et al. as the NUV divided by the largest single voided vol-
ume (functional bladder capacity) from a 24-hour diary [8,12]. 
A threshold of 1.5 was suggested by the authors. When we ap-
plied this threshold to our study population, the overall preva-
lence of NP was 30.2%. When we calculated the threshold for 
NI based on the 95th percentile, the new cutoff values were 2.6 
for men and 2.5 for women. 
 Our study also had certain limitations. We used a 1-day blad-
der diary in our study, although a 3-day diary would have been 
ideal. We did not consider this to be a major limitation because 
this study was planned as a part of a prevalence study rather 
than a clinical trial. Furthermore, only 55% of the participants 
filled out the bladder diaries accurately, and this rate might have 
decreased if the diary period were to have been increased. Since 
we focused on the definitions of nocturia and NP, we did not 
analyze the determinants or predictors of those conditions, al-
though we had a large database from our population-based 
prevalence study. Nevertheless, we suggest that the present 
study fills a scientific gap in this field; this gap was also pointed 
out by the NERI and NTT panelists, who encouraged more re-
search to determine population-based norms for NP and 
thresholds for nocturia [13,14].
 In this study, we showed that the definition of nocturia re-
mains controversial and that waking up once for voiding might 
be within the normal spectrum of behavior. Thus, the definition 
of nocturia should be modified to be waking up 2 or more times 
at night to void. When applied to a large population sample, the 
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current definition and the past definitions of NP resulted in 
high prevalence rates. Therefore, the definition of NP should be 
modified, and new cutoff values should be defined using the 
data of the present study and other forthcoming studies.
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